Table 1.
Pathological types | Number of cases (%) | References |
---|---|---|
Glomerular diseases |
||
IgA nephropathy |
31 (14.1%) |
[10,15,16,21,28,30] |
Mesangial proliferative glomerulonephritis |
22 (10%) |
[12,15,19,28,30] |
Post-infectious glomerulonephritis |
22 (10%) |
[12,29,30] |
Membranous nephropathy |
15 (6.8%) |
[6,10,15,17,21,28] |
Immune complex-trapping glomerulonephritis |
12 (5.5%) |
[13,29,30] |
Crescentic glomerulonephritis |
8 (3.6%) |
[12,13,16] |
Focal segmental glomerulosclerosis |
7 (3.2%) |
[10,12,13,15,16] |
Minimal change glomerulopathy |
3 (1.4%) |
[12,19] |
Membrano-proliferative glomerulonephritis |
3 (1.4%) |
[10,16,29] |
Lupus glomerulonephritis |
2 (1.0%) |
[29] |
Fibrillary glomerulonephritis |
1 (0.5%) |
[16] |
Necrotizing focal glomerulonephritis |
1 (0.5%) |
[29] |
Hepatitis-related nephritis |
1 (0.5%) |
[17] |
Vascular | ||
Hypertensive changes and arterionephrosclerosis |
19 (8.6%) |
[12,16,17,22,30] |
Atheroembolic renal disease |
2 (1.0%) |
[12] |
Thrombotic microangiopathy |
1 (0.5%) |
[13] |
Tubulointerstitial | ||
Tubulointerstitial nephritis |
50 (22.7%) |
[6,10,12,16,22,30] |
Pyelonephritis |
5 (2.3%) |
[12,16,22] |
Toxemia of pregnancy |
1 (0.5%) |
[28] |
Other |
14 (6.4%) |
[10,30] |
Total | 220 |
DN, diabetic nephropathy; IgA, immunoglobulin A; NDRD, non-diabetic renal disease.